Australian biotech company Ena Respiratory has said a nasal spray that it is developing to improve human immune system to fight common cold and flu significantly reduced coronavirus growth in a recent study on animals. INNA-051 reduced COVID-19 viral replication by up to 96% in ferrets, the company said. The study was led by British government agency Public Health England.